Formed in 2026 to take over the Laminar left atrial appendage program from Johnson & Johnson. The catheter-based device closes the appendage using rotational motion and leaves little implant material exposed in the left atrium.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
Unsubscribe anytime. We never sell the list.